APIM Therapeutics

0 followers


APIM Therapeutics is developing proprietary peptide drugs targeting PCNA (Proliferating Cell Nuclear Antigen).

Industries

+2

Headquarters

Stage

Employees

Links

Org chart

Kostas Alevizopoulos
Chief Executive Officer

Kostas Alevizopoulos

Collapse
Marit Otterlei
Chief Scientific Officer
Jens-Peter Marschner
Chief Medical Officer
Hans Olav Minsås
Chief Financial Officer
Gokhan Batur
Board Member